Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas L Palaskas

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Annals of Internal Medicine|November 16, 2020
In heart failure, adding empagliflozin to medical therapy reduced a composite of CV death or HF hospitalizationNicolas L Palaskas, Anita Deswal
Current Cardiology Reports|August 10, 2020
The Role of Echocardiography in the Cancer PatientNicolas L Palaskas, Juan Lopez-Mattei
Current Cardiology Reports|October 11, 2020
COVID-19 and Cardiovascular Health Among Patients with CancerNicolas L Palaskas, Efstratios Koutroumpakis, Anita Deswal
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|July 6, 2021
Cardiotoxicity of Immune Checkpoint Inhibitors: Beyond MyocarditisDemis N Lipe, Nicolas L Palaskas, Patrick Chaftari
JACC. Cardiooncology|October 31, 2024
Steroids in Immune Checkpoint Inhibitor MyocarditisNicolas L Palaskas, Bilal A Siddiqui, Anita Deswal
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2023
Cardiac Monitoring Guidelines in Clinical Trials and Post-Approval Surveillance for Patients Exposed to Anticancer Treatments: Do the Data Support the Recommendations?Michael S Ewer, Nicolas L Palaskas, Jay Herson
JACC. Cardiooncology|October 23, 2025
Troponin Surveillance in Patients Receiving Immune Checkpoint InhibitorsKeila C Ostos-Mendoza, Jennifer L McQuade, Nicolas L Palaskas
Blood Cancer Journal|May 29, 2026
Cardiotoxicity induced by multiple myeloma therapies: mechanistic convergence across proteasome inhibitors, CAR-T, and bispecific antibodiesArnav Ramnath Chatrathi, Krina Patel, Neeraj Saini, et al.
The American Journal of Emergency Medicine|March 5, 2022
The evolving landscape of chimeric antigen receptor T-cell therapy associated cardiotoxicityDemis N Lipe, Patrick Chaftari, Cielito Reyes-Gibby, et al.
Expert Review of Cardiovascular Therapy|April 18, 2020
Rise and fall of preoperative coronary revascularizationDeepa Raghunathan, Nicolas L Palaskas, Syed Wamique Yusuf, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Annals of Internal Medicine|November 16, 2020
In heart failure, adding empagliflozin to medical therapy reduced a composite of CV death or HF hospitalizationNicolas L Palaskas, Anita Deswal
Current Cardiology Reports|August 10, 2020
The Role of Echocardiography in the Cancer PatientNicolas L Palaskas, Juan Lopez-Mattei
Current Cardiology Reports|October 11, 2020
COVID-19 and Cardiovascular Health Among Patients with CancerNicolas L Palaskas, Efstratios Koutroumpakis, Anita Deswal
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|July 6, 2021
Cardiotoxicity of Immune Checkpoint Inhibitors: Beyond MyocarditisDemis N Lipe, Nicolas L Palaskas, Patrick Chaftari
JACC. Cardiooncology|October 31, 2024
Steroids in Immune Checkpoint Inhibitor MyocarditisNicolas L Palaskas, Bilal A Siddiqui, Anita Deswal
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2023
Cardiac Monitoring Guidelines in Clinical Trials and Post-Approval Surveillance for Patients Exposed to Anticancer Treatments: Do the Data Support the Recommendations?Michael S Ewer, Nicolas L Palaskas, Jay Herson
JACC. Cardiooncology|October 23, 2025
Troponin Surveillance in Patients Receiving Immune Checkpoint InhibitorsKeila C Ostos-Mendoza, Jennifer L McQuade, Nicolas L Palaskas
Blood Cancer Journal|May 29, 2026
Cardiotoxicity induced by multiple myeloma therapies: mechanistic convergence across proteasome inhibitors, CAR-T, and bispecific antibodiesArnav Ramnath Chatrathi, Krina Patel, Neeraj Saini, et al.
The American Journal of Emergency Medicine|March 5, 2022
The evolving landscape of chimeric antigen receptor T-cell therapy associated cardiotoxicityDemis N Lipe, Patrick Chaftari, Cielito Reyes-Gibby, et al.
Expert Review of Cardiovascular Therapy|April 18, 2020
Rise and fall of preoperative coronary revascularizationDeepa Raghunathan, Nicolas L Palaskas, Syed Wamique Yusuf, et al.
Pageof 8